NDAQ:RGC - Post Discussion
Post by
sungrin1309 on Aug 17, 2022 12:18pm
A sneak peak into RGC background
A sneak peak into RGC background Bioscience is an early-stage bioscience company focused on the research, development, and commercialization of Traditional Chinese Medicine. Regencell Chairman and CEO, Yat-Gai Au recently purchased more than $5.9 million in RGC shares. Majority shareholders of Regencell are insider investors. Regencell is comfortably poised amidst turbulent market conditions, especially for a biotech stock. The company has a list of successful clinical trials, with more to come in the year. https://seekingalpha.com/article/4534812-slow-and-steady-wins-the-race-with-regencell-bioscience
Be the first to comment on this post